Zobrazeno 1 - 9
of 9
pro vyhledávání: '"39"'
Publikováno v:
Transplantation proceedings. 32(7)
Investigator Assessment of the Utility of the TruGraf Molecular Diagnostic Test in Clinical Practice
Autor:
Sunil M. Kurian, Didier A. Mandelbrot, D. Maluf, C. Schieve, D. Lee, John J. Friedewald, A. Patel, James C. Rice, S. Rose, Richard J. Knight, Michael Abecassis, M. R. First, V. R. Peddi, Roslyn B. Mannon, Christopher L. Marsh, P. Lewis, J. David
Publikováno v:
Transplantation Proceedings. 51:729-733
Background TruGraf v1 is a well-validated DNA microarray-based test that analyzes blood gene expression profiles as an indicator of immune status in kidney transplant recipients with stable renal function. Methods In this study, investigators assesse
Autor:
J. Drozdrowski, Michal Wszola, Andrzej Chmura, K. Jędrzejko, Monika Bieniasz, D. Zygier, Leszek Pączek, Jolanta Gozdowska, Rafal Kieszek, Magdalena Durlik, Artur Kwiatkowski, Aleksandra Tomaszek, Piotr Domagala
Publikováno v:
Transplantation proceedings. 46(8)
An increase in the number of obese patients on transplantation waiting lists can be observed. There are conflicting results regarding the influence of body mass index (BMI) on graft function.We performed a single-center, retrospective study of 859 ad
Autor:
László Wagner, Imre Fehérvári, Enikő Sárváry, Zs. Máthé, Gábor Telkes, Robert M. Langer, I. Gaal, Marina Varga, Gy. Gaman, R. Chmel
Publikováno v:
Transplantation proceedings. 46(6)
Background According to the clinical trials, Advagraf (ADV) has efficacy and safety profile similar to Prograf (PROG). The aim of this study was to compare the graft functions, dosages, and tacrolimus (TAC) trough level profile curves of patients on
Kidney transplantation from donation after cardiac death donors in China--a single-center experience
Autor:
Yang Liu, J. Li, Su-xiong Deng, Gang Huang, Long-shan Liu, Jiang Qiu, Qing-Ling Fu, C. Wang, Likun Chen, Guanghao Chen, Ji-guang Fei
Publikováno v:
Transplantation proceedings. 44(4)
Objective To report clinical outcomes of kidney transplantation from cardiac death donors (DCD) in China, and to investigate its feasibility to expand the organ donor pool. Patients and methods We retrospectively studied clinical data of 46 DCD kidne
Autor:
N. Miyamoto, Yasunaru Sakuma, Takashi Yagisawa, M. Yashi, A. Nukui, T. Fujiwara, Nobuo Ishikawa
Publikováno v:
Transplantation proceedings. 40(7)
Introduction. According to the Japanese renal transplant registry 2005, 834 transplantations were performed using living donors. Among them 112 (13.4%) patients were transplanted from living donors before the initiation of maintenance dialysis. Preem
Autor:
Werviston DeFaria, Deborah Weppler, Enrique J. Martinez, Jang Moon, Jeffrey J. Gaynor, G. Selvaggi, Philip Ruiz, Panagiotis Tryphonopoulos, Juan Madariaga, Andreas G. Tzakis, S. Santiago, David Levi, Seigo Nishida, Tomoaki Kato
Publikováno v:
Transplantation proceedings. 38(6)
Background. Alemtuzumab (Campath-lH [C1H]) is a humanized monoclonal antibody directed against the CD 52 antigen that is present on the surface of T cells, B cells, natural killer cells and monocytes. We studied its application in intestinal transpla
Publikováno v:
Transplantation proceedings. 37(4)
Introduction Liver transplantation is the only established curative therapy for end-stage primary biliary cirrhosis (PBC). However, the influence of primary immunosuppression on long-term patient and graft survival is still controversial. Patients an
Autor:
M.-A Khammar, R Mahdavi-Zafarghandi
Publikováno v:
Transplantation proceedings. 33(5)
ND-STAGE RENAL DISEASE (ESRL) in children is rare. The incidence ranges from one to three new cases yearly per million population. Chronic renal failure in childhood leads to growth retardation, osteodystrophy, and central nervous system morbidity. R